Atrial Fibrillation Patients Do Not Benefit From Acetylsalicylic Acid

Sara Själander; Anders Själander; Peter J. Svensson; Leif Friberg

Disclosures

Europace. 2014;16(5):631-638. 

In This Article

Conclusion

Acetylsalicylic acid as monotherapy in stroke prevention of AF has no discernable protective effect against stroke, and may even increase the risk of ischaemic stroke in elderly patients. Thus, our data support the new European guidelines recommendation that ASA as monotherapy should not be used as stroke prevention in AF unless there is no alternative.[20]

processing....